AI tools to predict hospital stays are hampered by a string of shortcomings

You're reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. Remote patient monitoring company Biofourmis announced a $300 million Series D round this morning, a critical investment as the firm looks to products that not only identify when patients are likely to deteriorate, but can help manage their care. The company says that 20 hospitals have signed on to use its care at home services -- which includes monitoring devices and an app -- to help prevent costly ER care and readmissions. Next up: using patient data to drive treatment decisions, like titrating drug doses.